2026-05-20 04:57:13
A comprehensive guide to Niraparib (Zejula), a once-daily PARP inhibitor for maintaining remission in ovarian, fallopian tube, and peritoneal cancers. Learn about HRD selection, dosing by weight, and critical blood monitoring.
2025-10-19 11:44:20